Add BrightSurf on Google Email

Science News for February 21, 2000


Hurry up and wait

A recent study by Nigel Rawson found that the time taken to approve new drugs in Canada is significantly longer than in countries like Sweden and Australia. The median drug approval time in Canada was 518 days, compared to 371 days in Sweden.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·DateFeb 21, 2000

Bad medicine

Final-year medical students experience significant deterioration in vitality and work ability due to physical and emotional problems. The decline in health status may begin earlier than expected, highlighting the need for steps to address the issue.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·DateFeb 21, 2000

Drug for iron overload passes major safety hurdle, may benefit patients with thalassemia and other blood disorders

A new oral medication called deferiprone has been shown to have a rare side effect on white blood cells, but is considered a potential treatment option for patients with iron overload. The study found that the drug may benefit patients with thalassemia and other hemoglobin disorders who do not respond to conventional treatments.

SourceChildren's Hospital of Philadelphia·JournalBritish Journal of Haematology·DateFeb 21, 2000